132 related articles for article (PubMed ID: 10095772)
1. Identification of cyclin A/Cdk2 phosphorylation sites in B-Myb.
Bartsch O; Horstmann S; Toprak K; Klempnauer KH; Ferrari S
Eur J Biochem; 1999 Mar; 260(2):384-91. PubMed ID: 10095772
[TBL] [Abstract][Full Text] [Related]
2. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
Saville MK; Watson RJ
Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
[TBL] [Abstract][Full Text] [Related]
3. PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites.
Santilli G; Cervellera MN; Johnson TK; Lewis RE; Iacobelli S; Sala A
Oncogene; 2001 Dec; 20(57):8167-74. PubMed ID: 11781832
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
Bessa M; Saville MK; Watson RJ
Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation and activation of B-Myb by cyclin A-Cdk2.
Ziebold U; Bartsch O; Marais R; Ferrari S; Klempnauer KH
Curr Biol; 1997 Apr; 7(4):253-60. PubMed ID: 9094315
[TBL] [Abstract][Full Text] [Related]
6. Cyclin A1 directly interacts with B-myb and cyclin A1/cdk2 phosphorylate B-myb at functionally important serine and threonine residues: tissue-specific regulation of B-myb function.
Müller-Tidow C; Wang W; Idos GE; Diederichs S; Yang R; Readhead C; Berdel WE; Serve H; Saville M; Watson R; Koeffler HP
Blood; 2001 Apr; 97(7):2091-7. PubMed ID: 11264176
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT.
Li X; McDonnell DP
Mol Cell Biol; 2002 Jun; 22(11):3663-73. PubMed ID: 11997503
[TBL] [Abstract][Full Text] [Related]
8. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
Joaquin M; Watson RJ
J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of B-Myb regulates its transactivation potential and DNA binding.
Johnson TK; Schweppe RE; Septer J; Lewis RE
J Biol Chem; 1999 Dec; 274(51):36741-9. PubMed ID: 10593981
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
Bartusel T; Schubert S; Klempnauer KH
Gene; 2005 May; 351():171-80. PubMed ID: 15922873
[TBL] [Abstract][Full Text] [Related]
11. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
Morris L; Allen KE; La Thangue NB
Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
[TBL] [Abstract][Full Text] [Related]
12. Matrix-independent activation of phosphatidylinositol 3-kinase, Stat3, and cyclin A-associated Cdk2 Is essential for anchorage-independent growth of v-Ros-transformed chicken embryo fibroblasts.
Uttamsingh S; Zong CS; Wang LH
J Biol Chem; 2003 May; 278(21):18798-810. PubMed ID: 12646574
[TBL] [Abstract][Full Text] [Related]
13. The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A.
Luciani MG; Hutchins JR; Zheleva D; Hupp TR
J Mol Biol; 2000 Jul; 300(3):503-18. PubMed ID: 10884347
[TBL] [Abstract][Full Text] [Related]
14. B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation.
Lane S; Farlie P; Watson R
Oncogene; 1997 May; 14(20):2445-53. PubMed ID: 9188859
[TBL] [Abstract][Full Text] [Related]
15. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
[TBL] [Abstract][Full Text] [Related]
16. B-Myb repressor function is regulated by cyclin A phosphorylation and sequences within the C-terminal domain.
Petrovas C; Jeay S; Lewis RE; Sonenshein GE
Oncogene; 2003 Apr; 22(13):2011-20. PubMed ID: 12673206
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization.
Petersen BO; Lukas J; Sørensen CS; Bartek J; Helin K
EMBO J; 1999 Jan; 18(2):396-410. PubMed ID: 9889196
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex.
Rogatsky I; Trowbridge JM; Garabedian MJ
J Biol Chem; 1999 Aug; 274(32):22296-302. PubMed ID: 10428798
[TBL] [Abstract][Full Text] [Related]
19. A mutant E2F-1 transcription factor that affects the phenotype of NIH3T3 fibroblasts inefficiency associates with cyclin A-cdk2.
Jordan-Sciutto KL; Hall DJ
Biochem Cell Biol; 1998; 76(1):37-44. PubMed ID: 9666304
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of E2F-1 by cyclin A-cdk2.
Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]